Pradžia › 2 tipo cukrinis diabetas › Nebraska
2 tipo cukrinis diabetas klinikiniai tyrimai Nebraska
14 tyrimai dėl 2 tipo cukrinis diabetas ieško dalyvių vietose Nebraska.
Miestai Nebraska
Oficialus tyrimo tekstas (anglų kalba)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Methodist Physicians Clinic, Fremont
- Quality Clinical Research - Omaha, Omaha
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07064473A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Bryan Heart, Lincoln
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- University Of Nebraska Medical Center, Omaha
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07595549A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Omaha
- Research Site, Omaha
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07784270Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- University of Nebraska Medical Center, Omaha
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Omaha
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Lincoln, Lincoln
- Velocity Clinical Research, Omaha, Omaha
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07296484A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Omaha
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Methodist Phys. Clinic, Omaha
Renkami dalyviai3 fazė
Amžius 45 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Elkhorn
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT07662109Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Methodist Physicians Clinic, Fremont
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-17 · NCT07527650HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Velocity Clinical Research Norfolk, Norfolk
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-23 · NCT07546929Blood Markers of Early Pancreas Cancer
- Unversity of Nebraska Medical Center, Omaha
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2026-02-02 · NCT03568630SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
- University of Nebraska Medical Center, Omaha
Renkami dalyviai
Amžius nuo 19 iki 89 · Visoms lytims · Atnaujinta 2025-10-22 · NCT06480786Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.